Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party
2020 ◽
Vol 55
(9)
◽
pp. 1763-1772
◽
2019 ◽
Vol 98
(10)
◽
pp. 2389-2398
◽
2019 ◽
Vol 55
(3)
◽
pp. 595-602
◽
2021 ◽
Vol 27
(3)
◽
pp. S30-S32